Scroll below vaccine planning and communication resources to see an article listing.
How can you be sure a #COVID19 vaccine will be safe? The @US_FDA thoroughly tests vaccines before they are offered to the public. https://www.cdc.gov/vaccines/hcp/conversations/ensuring-safe-vaccines.html [attach image]
Curious about #COVID19 vaccine safety? This graphic explains the @US_FDA review process for all new vaccines. https://www.cdc.gov/vaccines/hcp/conversations/ensuring-safe-vaccines.html [attach image]
The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them.
Stat; December 2, 2020.
‘Time is of the essence here.’ High-risk groups await state vaccine plan
Boston Globe; December 1, 2020. Massachusetts could see two vaccines arrive by mid- to late December
New York Times; November 30, 2020. Vaccines typically require years of research and testing before reaching the clinic, but scientists are racing to produce a safe and effective coronavirus vaccine by next year. Researchers are testing 57 vaccines in clinical trials on humans, and at least 87 preclinical vaccines are under active investigation in animals.
What you need to know about the AstraZeneca, Moderna and Pfizer vaccines
Washington Post; November 30, 2020. In the third such announcement in as many weeks, AstraZeneca revealed Monday that its vaccine candidate, developed by Oxford University, is up to 90 percent effective in clinical trials. Pfizer and its German partner, BioNTech, and Moderna have each reported vaccines that are 95 percent effective in trials.
These are the top coronavirus vaccines to watch
Washington Post; November 30, 2020. We are tracking 200 experimental vaccines aimed at ending the pandemic, a scientific quest moving at record-breaking speed.
The Last, ‘Ultra-Cold’ Mile for Covid-19 Vaccines
Wired; November 23, 2020. Two vaccines are nearly here—but their unusual storage requirements could deprive the rural areas that need them most. A tech fix might be coming.
Pfizer and BioNTech have applied for emergency approval for their Covid-19 vaccine.
Vox; November 20, 2020. The companies say their vaccine could begin distribution to high-risk people by mid-December.
Will the Covid vaccine be safe? What the scientists want to see.
NBC News, November 20, 2020. The first experimental coronavirus vaccines could be available by the end of the year, and while that’s welcome news for public health officials, surveys have shown that people’s trust in a Covid-19 vaccine remains on shaky ground.
The End of the Pandemic Is Now in Sight.
The Atlantic, November 18, 2020. A year of scientific uncertainty is over. Two vaccines look like they will work, and more should follow.
What Moderna’s Covid-19 vaccine results mean for ending the pandemic
Vox; November 16, 2020. Moderna says its vaccine is 95 percent effective. Here’s what you need to know.
Efforts intensify to determine those first in line to receive a COVID-19 vaccine — and build trust in skeptical communities.
Boston Globe; November 15, 2020. With a potential COVID-19 vaccine suddenly closer on the horizon, planning is intensifying over which Massachusetts residents will be first in line to receive the shots and how to persuade communities that are deeply mistrustful of vaccines and the health care system to step forward.